An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer’s Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model

Alzheimer’s disease (AD) is the most common form of dementia, but there is still no available treatment. Δ9-tetrahydrocannabinol (THC) is emerging as a promising therapeutic agent. Using THC in conventional high doses may have deleterious effects. Therefore, we propose to use an ultra-low dose of TH...

Descripción completa

Detalles Bibliográficos
Autores principales: Nitzan, Keren, Ellenbogen, Leah, Bentulila, Ziv, David, Dekel, Franko, Motty, Break, Emanuela P., Zoharetz, Michal, Shamir, Alon, Sarne, Yosef, Doron, Ravid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408848/
https://www.ncbi.nlm.nih.gov/pubmed/36012711
http://dx.doi.org/10.3390/ijms23169449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408848/
https://www.ncbi.nlm.nih.gov/pubmed/36012711
http://dx.doi.org/10.3390/ijms23169449

Ejemplares similares